Clinical Trial Update: A Study to Investigate the Safety and Pharmacodynamics of a Single Intrathecal Injection (IT) of INS1202 in Participants With Amyotrophic Lateral Sclerosis (ALS) [Phase 1]

View source ↗

Summary

Phase 1 study to evaluate the safety and pharmacodynamics of a single intrathecal injection of INS1202 in participants with amyotrophic lateral sclerosis. The s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• INS1202

Snippet

Sponsor: Insmed Gene Therapy LLC | Conditions: Amyotrophic Lateral Sclerosis | Phase 1 | Status: RECRUITING